Parkinson's Disease News

GSK Launches ReQuip XL R ropinirole Prolonged-release Tablets A New Once Daily Formulation For The Treatment Of Parkinson's Disease

Sun, 22 Jun 2008 22:20:05 GMT

GlaxoSmithKline (GSK) have announced the launch of a new treatment for Parkinson's disease (PD) in the UK.

Neural Cell Transplants May Help Those With Parkinson's Disease

Sun, 22 Jun 2008 22:20:04 GMT

The current issue of Cell Transplantation (Vol. 17:4) features a number of publications by researchers seeking new ways to treat Parkinson's disease (PD), a neurological disease characterized by muscle rigidity, tremor and slowed physical movements related to insufficient levels of dopamine (DA) in the basal ganglia of the brain, by using primate models to examine the potential therapy role of transplanted cells.

Full text

Neurologists And Clinicians From Rush University Medical Center Present Latest Research Findings At The Movement Disorder Society Meeting

Sun, 22 Jun 2008 22:20:02 GMT

Leading neurologists and other clinicians from Rush University Medical Center are presenting new basic and clinical research findings at the Movement Disorder Society's 12th International Congress of Parkinson's Disease and Movement Disorders meeting in Chicago, June 22-26.

Full text

Buck Institute And Q Therapeutics Form Stem Cell Collaboration To Combat Parkinson's Disease

Sat, 21 Jun 2008 19:00:06 GMT

The Buck Institute for Age Research and Q Therapeutics, Inc. announced an agreement to collaborate on novel routes to combat Parkinson's disease.

Full text

BrainStorm Cell Therapeutics NTF Cells Shows Significant Advantage In Pre-Clinical Study For Parkinson's Disease

Sat, 21 Jun 2008 19:00:04 GMT

BrainStorm Cell Therapeutics Inc. (OTCBB:BCLI), a leading developer of adult stem cell technologies and therapeutics, announced that in a pre-clinical study that was conducted with Tel Aviv University between February and May 2008, signs of impaired motor behavior in a rat model of Parkinson's improved following transplantation of BrainStorm's unique Neurotrophic Factor Cells (NTF).

Full text

Brainstorm Cell Therapeutics Chief Scientist, Dr. Daniel Offen, To Present Results From New Parkinson's Study At International Stem Cell Meeting

Fri, 20 Jun 2008 15:00:04 GMT

BrainStorm Cell Therapeutics Inc. (OTCBB: BCLI), a leading developer of adult stem cell technologies and therapeutics, announced that Dr.

Full text

Adult Stem Cell Findings Offer New Hope For Parkinson's Cure

Thu, 19 Jun 2008 11:40:03 GMT

Research released today provides evidence that a cure for Parkinson's disease could lie just inside the nose of patients themselves.

Full text

BBVA Foundation International Study On Attitudes To Stem Cell Research

Wed, 18 Jun 2008 08:00:19 GMT

Unlike most scientific and technological advances, which tend to take their place silently in society, biotechnology often finds itself the center of public debate and regulatory attention, due partly to the moral issues posed by many of its applications.

Full text

23andMe And The Parkinson's Institute Announce Initiative To Advance Parkinson's Disease Research

Wed, 18 Jun 2008 08:00:17 GMT

23andMe, a privately-held personal genetics company, and The Parkinson's Institute and Clinical Center ("Parkinson's Institute") announced a research initiative under which Parkinson's Institute patients, with financial support from The Michael J.

Full text

EMEA Application For Nenad R lisuride Transdermal Patch And Subcutaneous Infusion For Parkinson's And Restless Leg Syndrome

Tue, 17 Jun 2008 04:40:03 GMT

Axxonis Pharma AG announces the submission of a marketing authorisation application to the European Medicines Agency (EMEA) for Nenad(R) (lisuride transdermal patch as add-on therapy for Parkinson's Disease and for Restless Legs Syndrome, and subcutaneous (sc) lisuride infusion fo.

Full text